Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials

BackgroundChronic plaque psoriasis is a persistent inflammatory skin condition characterized by erythematous, scaly plaques, significantly impairing the quality of life of affected individuals. Mirikizumab, a humanized monoclonal antibody targeting interleukin-23 (IL-23) p19 subunit, has shown promi...

Full description

Saved in:
Bibliographic Details
Main Authors: Taimoor Ashraf, Anand Kumar Malani, Dileep Kumar, Raja Subhash Sagar, Sahil Raj, Payal Kumari, Aanchal Kumari, Simran Bajaj, Muhammad Abdul Basit, Muhammad Murad, Vikash Kumar, Ayush Kumar
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Medicine
Subjects:
psoriasis
plaque psoriasis
mirikizumab
interleukin-23
psoriasis area and severity index
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1591787/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1591787/full

Similar Items